NSE filing, NSE: GML. Summary written from the filing by ALFA Finder's alert engine.
Galaxy Medicare Ltd: key numbers
- Share price
- ₹18.00
- Market cap
- ₹27.31 Cr
- Revenue (annual)
- ₹40.00 Cr
- Net profit (annual)
- ₹3.42 Cr
- P/E (TTM)
- 8.0×Sector 52.0×
- Promoter holding
- 73.36%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Galaxy Medicare Ltd
All →Galaxy Medicare Annual General Meeting
Galaxy Medicare Limited held its 34th Annual General Meeting on September 28, 2026. Shareholders approved all agenda items, including the adoption of financial statements and dividend declaration.
Galaxy Medicare Dividend
Galaxy Medicare Limited has fixed September 11, 2026, as the record date for determining shareholder entitlement to the final dividend for the 2025-26 financial year.
Galaxy Medicare Other Announcement
Galaxy Medicare Limited announced the re-appointment of Mr. Purnendu Bhusan Mohanty as Internal Auditor. The appointment is for a term of 12 months.
Galaxy Medicare Annual General Meeting
Galaxy Medicare approved the FY 2025-26 Annual Report and the notice for its 34th AGM, scheduled for September 28, 2026.
Galaxy Medicare Results Correction
Galaxy Medicare Limited submitted a Working Capital Certificate and corrected a clerical error regarding paid-up equity share capital in its XBRL filing.
Galaxy Medicare Other Announcement
Galaxy Medicare Limited filed a compliance report. The company stated that corporate governance reporting requirements for SME platforms are not applicable.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.